Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2019
Price : $35 *
At a glance
- Drugs Nitric oxide (Primary)
- Indications Bronchiolitis; Respiratory syncytial virus infections
- Focus Therapeutic Use
- 15 Jul 2019 According to a Beyond Air media release, the company has changed its name from AIT Therapeutics to Beyond Air.
- 04 Jun 2019 According to an AIT Therapeutics media release, the company announced that the proceeds of the PIPE financing will be used to complete this trial.
- 21 Apr 2015 Data will be presented at the American Thoracic Society 2015 International Conference, according to an Advanced Inhalation Therapies media release.